BAAT and hepatocellular carcinoma: Elevated levels of the bile acid–conjugating enzyme BAAT (bile acid-CoA:amino acid N-acyltransferase) were found in HCC patients, with its deletion in mice leading to enhanced tumor-specific T cell responses and reduced tumor growth.